The global clinical decision support systems (CDSS) market is projected to reach USD 2.2 billion by 2027 from USD 1.5 billion in 2022, at a CAGR of 7.9% during the forecast period. The growth of this market is driven by the implementation of government regulations and initiatives to promote the adoption of HIT solutions, increasing adoption of CDSS-enabled EHRs, growing collaborations and partnerships between stakeholders, rising incidence of medication errors, and the development mHealth and big data tools. However, high investment requirements for the implementation of CDSS and inadequate interoperability coupled with rising data security concerns are factors expected to restrain the growth of this market during the forecast period.
The Prominent players in this market are Cerner Corporation (US), Change Healthcare (US), Epic Systems (US), MEDITECH (US), Philips Healthcare (Netherlands), Wolters Kluwer N.V. (Netherlands), Zynx Health (US), Elsevier B.V. (UK), IBM Watson Health (US), Allscripts Healthcare LLC (US), athenahealth (US), NextGen Healthcare (US), Siemens Healthineers (US), EBSCO Health (US), GE Healthcare (US), eClinicalWorks (US), RAMPMedical (Germany), The Medical Algorithms Company Limited (UK), Hera-MI (France), CureMD Healthcare (US), CareCloud, Inc (US), Visual DX (US), Stanson Health (US), First Databank, Inc (US), and Strata Decision Technology (US). These players are increasingly focusing on new product launches and partnerships to expand their product offerings in the clinical decision support systems market.
To know about the assumptions considered for the study download the pdf brochure
Wolters Kluwer Health (Netherland) is a leading player in the clinical decision support systems market. The company offers a wide range of CDSS solutions. Wolters Kluwer Health has a prominent position in the market, owing to its large customer base and user-friendly solutions. The firm’s standalone CDSS solutions and integrated CDSS solutions provide informed & updated information to its end users. The company is present in more than 180 countries, including the US, the Netherlands, Brazil, Germany, Italy, France, Belgium, and the UK.
Cerner (US) ranks second in the market and is a leading provider of healthcare information technology (HCIT) solutions and support & maintenance services. The company generates revenue from licensed software, technology resale, professional services, managed services, support and maintenance, and subscriptions. Cerner offers solutions on the unified Cerner Millennium architecture and the HealtheIntent cloud-based platform. The HealtheIntent platform is a cloud-based platform designed to scale large populations while facilitating the health & care of a person at the provider level. Cerner operates in North America, Europe, the Asia Pacific, and Latin America. Some of its major subsidiaries include Cerner Deutschland GmbH (Germany), Cerner France, Cerner Iberia S.L. (Spain), Cerner Ireland Ltd., and Cerner Limited (UK).
IBM (US) is also the leading player in the clinical decision support systems market. The company has developed many cloud-based solutions and is a pioneer in cloud software. It invests a significant share of its revenue into research and development. The company generates revenue from four business segments: Software, Consulting, Infrastructure, and Financing. IBM has licensed software to over 6,000 clinics & labs, 1,500 hospitals, 250 medical device manufacturers, and leading pharmaceutical companies globally.
Clinical Decision Support Systems (CDSS) Market by Component (Services, Software), Delivery (On-premise, Cloud), Product (Standalone, Integrated), Application (Advanced, Therapeutic, Diagnostic), Interactivity (Active, Passive) - Global Forecasts to 2027
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE